NCT06592222
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Pfizer New York, United States
Clinical trial condition
Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.
NCT06592222
NCT04689659
NCT02577406
NCT04340167
NCT03080883
NCT00239616
Not specified
NCT04325841
NCT04128488
NCT02534909
NCT04283097